Genmab — Oktober 2018
-
Myelomatosebladet: "Hvorfor virker daratumumab ikke på alle?". Artikel af Plesner i septembernummeret. https://www.myelomatose.dk/content/uploads/2018/09/Myelomatosebladet-3-2018-Hjemmeside-compressed.pdf
-
Tusinde tak Bulder. Jeg har lagt linket i debatten. http://www.proinvestor.com/index.php?p=debat_1&postid=76362
-
-
However, he did note some frustration with third-party manufacturers in the occasional delays in securing space. “We like to claim more space [then we initially expect] at a CMO to avoid delays in production,” he said, adding more flexible CMO models are needed going forward.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind